Weave, an all-in-one customer communication platform for small business, and Sycle, a provider of audiology practice management software, announced the launch of an integration to bring more products and services direct to practices in a simple, streamlined solution.
Read More
Summative Usability Validation has been completed, which helps demonstrate that users can “safely and correctly use the Intricon self-fitting technology,” and the clinical trial of the software can move forward.
Read More
GN Hearing, the parent company of ReSound and Beltone, announced in a profit warning that it is experiencing delays in product development deliverables leading to postponement of key product launches planned for H2 2021. The company has decided to initiate a transformation of R&D with the objective to increase quality, predictability of delivery times, and R&D efficiency.
Read More
The event will take place in an inclusive hybrid format, both in-person at the Ritz-Carlton, Naples, and as a virtual event online, November 5-7, 2021. The FCOM2021 agenda is said to feature “some of the brightest minds in the multi-specialties of ear, nose, and throat medicine and surgery.”
Read More
Eargo disclosed in a Securities and Exchange Commission filing that “it is the target of a criminal investigation by the Department of Justice related to insurance reimbursement claims the company has submitted on behalf of its customers covered by federal employee health plans.” Its stock price was as high as $76.75 in mid-February, but opened today at $6.60.
Read More
While provider participation in managed care remains optional, managed care is now an integral part of US healthcare, and hearing care as a supplemental benefit continues to grow in private and public health plans. Part 1 (published in September) of this 3-part series was a primer on health insurance and managed care. In Part 2, we investigate the recent growth of managed care and the expansion of supplemental benefits such as dental, vision, and hearing care and common perceptions and criticisms of managed care among hearing healthcare providers.
Read More
Starkey announced the launch of Listen Carefully, an initiative aimed at “bridging the conversation between hearing healthcare providers and lawmakers in Washington, DC.”
Read More
Starkey announced that it welcomed US Senator Amy Klobuchar of Minnesota to its global corporate headquarters last week. During the visit, Senator Klobuchar toured Starkey’s technology center and manufacturing facilities.
Read More
It is still too early in the pandemic to make definitive statements about the full impact of the COVID-19 virus on the auditory/vestibular and central auditory systems. Author Bob DiSogra, AuD, advises that hearing care professionals should revise their Case History forms and consider adding tests for auditory processing disorders and a cognitive screening in order to make the appropriate referral(s) for patients. Counseling will continue to be a major part of the patient’s experience with hearing care clinicians.
Read More
While provider participation in managed care remains optional, managed care is now an integral part of US healthcare. Hearing care as a supplemental benefit will continue to grow in private and public health plans. Author Carrie Meyer, AuD, says it is critical that audiologists and hearing aid specialists understand the dynamics of managed care and become well informed to make the best decisions for their practices and their patients in this rapidly changing healthcare environment. Part 1 of this 3-part series is a primer on health insurance and managed care.
Read More
The ultra-fast signal processing found in Widex MOMENT PureSound hearing aids is designed to overcome long-standing barriers to great sound quality, and speech understanding and EEG data also suggest that users benefit from eliminating delay-based distortion.
Read More
‘New York Times’ Personal Health writer Jane Brody, she discusses how new legislation related to coverage of hearing care coupled with increasingly innovative hearing aid design, may compel greater hearing device adoption among people with untreated hearing loss.
Read More
Nuheara has engaged National Acoustics Laboratories (NAL) under the terms of a Clinical Trial Agreement (CTA) to assist with conducting clinical trials for obtaining FDA and CE compliance for its hearing devices.
Read More
Bose announced the new SoundControl Hearing Aids — the “first FDA-cleared, direct-to-consumer hearing aid developed for adults with perceived mild-to-moderate hearing loss.”
Read More
California Attorney General Rob Bonta issued a consumer alert warning Californians to exercise caution when purchasing direct-to-consumer hearing products, such as hearing aids, over-the-counter or online.
Read More